The learning curve of laparoscopic single-site total hysterectomy with conventional laparoscopic instruments

使用传统腹腔镜器械进行单孔腹腔镜全子宫切除术的学习曲线

阅读:2

Abstract

Total hysterectomy is a relatively intricate surgical procedure in clinical practice. Laparoscopic total hysterectomy has become widely adopted in clinical settings. With the clinical advancement of single-port technology, single-port laparoscopy (SL) has garnered extensive popularity due to its safety and aesthetic appeal. This method involves entering the abdominal cavity through a single incision at the umbilicus, offering benefits such as minimal trauma, rapid recovery, and improved cosmesis. However, the high operational complexity results in a longer learning curve. This study retrospectively analyzed cases of laparoscopic total hysterectomy performed at the First People's Hospital of Xiaoshan District, Hangzhou City, from January 2020 to October 2024. The analysis included 50 cases, with 25 conducted via SL and 25 via conventional 3-port laparoscopy (CL). Various parameters were collected, including body mass index, uterine size, operative duration, changes in hemoglobin levels, leukocyte levels, neutrophil levels, C-reactive protein levels, and patient fever incidence. The cumulative sum (CUSUM) technique was employed for learning curve analysis to assess surgical proficiency. CUSUM analysis is a statistical method to monitor cumulative deviations from a target value, was used to objectively quantify the learning process by tracking operative time trends across sequential cases. This study showed that there were no statistically significant differences in the baseline characteristics and postoperative changes between the 2 groups. CUSUM analysis revealed a proficiency threshold at 12 cases, after which SL operative time (123 ± 15 min) matched CL (118 ± 14 min; P = .32). In total hysterectomy procedures, once proficiency is achieved, SL can yield safety outcomes comparable to those of CL. These findings provide valuable guidance for gynecologists interested in adopting SL. As technology continues to evolve and experience accumulates, SL is poised to offer patients an increasing array of minimally invasive treatment options.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。